Inhibitors of sodium–glucose cotransporter 2 (SGLT2) are known to improve cardiovascular and renal outcomes in patients with type 2 diabetes. Until recently, less was known about the effects of SGLT2 inhibitors on heart failure. In this episode of Curbside Consults, we...

SGLT2 Inhibitors in Heart Failure Management with Dr. John McMurray

This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.

Share SGLT2 Inhibitors in Heart Failure Management with Dr. John McMurray

Sign up to save your podcasts

SGLT2 Inhibitors in Heart Failure Management with Dr. John McMurray

SGLT2 Inhibitors in Heart Failure Management with Dr. John McMurray

More shows like Curbside Consults

NEJM Interviews

NEJM Journal Watch Podcasts: Clinical Conversations

NEJM This Week

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

Leadership Conversations

Core IM | Internal Medicine Podcast

Run the List

NEJM AI Grand Rounds

Intention to Treat

Not Otherwise Specified